Previous close | 63.12 |
Open | 62.74 |
Bid | 62.39 x 300 |
Ask | 62.47 x 200 |
Day's range | 62.23 - 63.32 |
52-week range | 42.75 - 64.47 |
Volume | |
Avg. volume | 766,373 |
Market cap | 3.38B |
Beta (5Y monthly) | 0.94 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
LONDON, May 01, 2024--LivaNova PLC reported results for the quarter ended March 31, 2024 and raised full-year 2024 revenue and adjusted diluted earnings per share guidance.
LONDON, April 30, 2024--LivaNova PLC announced that Ahmet Tezel, Ph.D., will join the Company as Chief Innovation Officer, effective May 13, 2024.
LONDON, April 25, 2024--LivaNova's wholly-owned U.S. subsidiary, LivaNova USA, Inc., is providing notice to U.S. patients regarding a cybersecurity incident in late 2023.